WuXi Biologics to sell Ireland vaccine facility to Merck for $500 million

Reuters
06 Jan
WuXi Biologics to sell Ireland vaccine facility to Merck for $500 million

Jan 6 (Reuters) - WuXi Biologics 2269.HK said on Monday its unit, WuXi Vaccines Ireland, will sell its vaccine facility in Ireland to Merck MRK.N for about $500 million.

(Reporting by Sneha S K; Editing by Krishna Chandra Eluri)

((Sneha.SK@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10